publiclawlibrary.org

Maricopa County Sheriff’s Office Faces Pressure to Resolve $315 Million Racial Profiling Case Backlog by 2026, Amid Critiques of Outsourced Investigation Efforts

by

PHOENIX — The Maricopa County Sheriff’s Office, grappling with a lingering scandal over racial profiling dating back to 2007, continues to face oversight by a court-appointed monitor, a predicament costing taxpayers nearly $315 million to date. This oversight follows a significant lawsuit during former Sheriff Joe Arpaio’s tenure, which accused the agency of systematically targeting Latinos. Currently, the sheriff’s office is addressing a substantial backlog of over 1,000 internal investigations involving its own employees, some of which have been unresolved for years. Judge G. Murray Snow, who presides over the case, has recently expressed his … Read more

Jury Orders Abbott to Pay $495 Million Over Premature Infant Formula Claims

by

Chicago — A federal jury has ordered health care company Abbott to pay $495 million in damages after finding that the company’s infant formula products were linked to premature infants developing a serious gastrointestinal disease. This landmark case has cast a spotlight on the safety standards and regulatory oversight of products intended for some of society’s most vulnerable individuals—premature babies. The jury’s verdict concluded that Abbott was responsible for the widespread distribution of formulas that allegedly contributed to infants developing necrotizing enterocolitis (NEC), a dangerous condition predominantly affecting premature infants. This condition can lead to … Read more

Weight-Loss Drug Makers Glean Strategic Insights from U.S. Litigation History

by

New York — As the United States grapples with rising obesity rates, manufacturers of the weight-loss drug class known as glucagon-like peptide-1 receptor agonists, or GLP-1, are drawing increased legal scrutiny. With this pharmaceutical success comes a lurking fear of mass tort litigation, a recurring theme in America’s complicated relationship with promising yet potentially risky medications. GLP-1 weight-loss drugs, lauded for their effectiveness in combating obesity, now face the challenge of navigating the perilous waters of American litigation. This scenario isn’t new. The history of pharmaceuticals in the U.S. is replete with legal battles over … Read more

Governor Newsom Proposes Two-Year Delay to California’s Groundbreaking Climate Disclosure Requirements for Large Corporations

by

SACRAMENTO, Calif. — Governor Gavin Newsom is pushing for a significant postponement in California’s pioneering climate disclosure laws. These laws, the first of their kind in the nation, affect companies doing business within the state that generate more than $500 million in annual revenue. Newsom’s new legislative suggestions advocate for shifting the compliance deadlines back by two years, citing feasibility concerns and the economic burdens they impose on businesses. Under the proposed amendments, businesses with an annual revenue exceeding $1 billion would now have until 2028 to disclose their direct and indirect greenhouse gas emissions, … Read more